{
    "clinical_study": {
        "@rank": "9925", 
        "arm_group": {
            "arm_group_label": "endocarditis", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The diagnosis of prosthetic valve endocarditis (PVE) remains challenging. In PVE cases,\n      initial echocardiography is normal or inconclusive in almost 30% of cases, leading to a\n      decreased diagnostic accuracy for the modified Duke criteria.\n\n      Aims: The investigators sought to determine the value of 18F-fluorodeoxyglucose positron\n      emission tomography/computed tomography (18F-FDG PET/CT) for diagnosing PVE.\n\n      Methods: In two referral French centers (Timone Hospial, Marseille and Georges Pompidou\n      European Hospital, Paris), the investigators plan to include consecutive patients suspected\n      of having PVE. All of the patients will be subjected to clinical, microbiological, and\n      echocardiographic evaluation. Cardiac PET/CT will be performed at admission and the data\n      analysis will be based on visual interpretation and quantitative measurement of FDG uptake\n      (SUVmax). The final diagnosis will be defined according to the clinical and/or pathological\n      modified Duke criteria determined during a 3-month follow-up (gold standard)."
        }, 
        "brief_title": "Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis", 
        "completion_date": {
            "#text": "March 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Prosthetic Valve Endocarditis (PVE)", 
        "condition_browse": {
            "mesh_term": "Endocarditis"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  unexplained persistent or recurrent fever >38\u00b0C;\n\n          -  and/or unexplained increased serum C-reactive protein (CRP) level >10 mg/L; and/or\n             positive blood cultures, independent of the echocardiographic analysis results;\n\n          -  and/or  positive serological testing for Coxiella burnetii, Bartonella spp.,\n             Mycoplasma pneumoniae, Legionella pneumophila, Aspergillus spp., or Tropheryma\n             whipplei;\n\n          -  and/or a mass or a new partial prosthetic valve dehiscence observed using\n             echocardiography.\n\n        Exclusion Criteria:\n\n          -  pregnancy,\n\n          -  an inability to lie flat,\n\n          -  a need for urgent cardiac surgery,\n\n          -  hemodynamic instability,\n\n          -  cardiac surgery <1 month ago,\n\n          -  and a blood glucose level >1.8 g/L. Patients with a poor PET/CT image quality"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "174", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01916005", 
            "org_study_id": "2013-A00056-39", 
            "secondary_id": "2013-01"
        }, 
        "intervention": {
            "arm_group_label": "endocarditis", 
            "intervention_name": "18F-FDG PET/CT", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "August 1, 2013", 
        "location": {
            "contact": {
                "email": "franck.thuny@ap-hm.fr", 
                "last_name": "franck thuny"
            }, 
            "facility": {
                "address": {
                    "city": "Marseille", 
                    "country": "France", 
                    "zip": "13354"
                }, 
                "name": "Assistance Publique Hopitaux de Marseille"
            }, 
            "investigator": {
                "last_name": "franck THUNY", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Diagnostic Value of 18F-fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in Prosthetic Valve Endocarditis", 
        "overall_contact": {
            "email": "franck.thuny@aphm.fr", 
            "last_name": "FRANCK THUNY"
        }, 
        "overall_official": {
            "affiliation": "Assistance Publique Hopitaux De Marseille", 
            "last_name": "LOIC MONDOLONI", 
            "role": "Study Director"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "18F-fluorodeoxyglucose positron emission tomography", 
            "measure": "the diagnosis of prosthetic valve infective endocarditis", 
            "safety_issue": "No", 
            "time_frame": "39months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01916005"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "description": "the other diagnostic parameters of PET/CT (specificity and predictive values)", 
                "measure": "the reproducibility of the technique,", 
                "safety_issue": "No", 
                "time_frame": "39 months"
            }, 
            {
                "description": "the other diagnostic parameters of PET/CT (specificity and predictive values)", 
                "measure": "the comparison of the sensitivity of PET/CT with that of echocardiography,", 
                "safety_issue": "No", 
                "time_frame": "39 MONTHS"
            }, 
            {
                "description": "the other diagnostic parameters of PET/CT (specificity and predictive values)", 
                "measure": "the rate of detection of embolic events,", 
                "safety_issue": "No", 
                "time_frame": "39 MONTHS"
            }, 
            {
                "description": "the other diagnostic parameters of PET/CT (specificity and predictive values)", 
                "measure": "the prognostic value of the technique (death/valve surgery)", 
                "safety_issue": "No", 
                "time_frame": "39 MONTHS"
            }
        ], 
        "source": "Assistance Publique Hopitaux De Marseille", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique Hopitaux De Marseille", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}